Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
High-Dose Ribavirin with Epoetin Beta in HIV-HCV Co-infection (PERICO)
NCT00526448Phase 4Unknown
- Start
- Jun 2007
- Modality
- Orthosteric Ligands, Metabolically Activated Prodrugs
- Countries
- 1
01
Overview
A Phase 4 trial of ribavirin in hepatitis C (HCV). Status: unknown.
02
Drugs
ribavirin
03
Conditions
hepatitis C (HCV)
Beyond the preview
Go deeper on NCT00526448.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00526448.